4,639 research outputs found

    Topology of full QCD

    Get PDF
    We study topological properties of SU(3) gauge theory using improved cooling. In the absence of fermions, we measure a topological susceptibility of (182(8)MeV)4(182(8) MeV)^4 and an instanton size ∌0.6\sim 0.6 fm. In the presence of light staggered fermions and across the chiral transition, the susceptibility drops in a manner consistent with the quenched case, and the instanton size changes little. No significant formation of bound instanton-antiinstanton pairs is observed, in particular not along the Euclidean time direction for T>TcT > T_c.Comment: 3 pages, 3 PostScript figures (one in color); Talk presented at LAT9

    Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer

    Get PDF
    Epidermal growth factor receptor (EGFR) inhibitors such as erlotinib are novel effective agents in the treatment of EGFR-driven lung cancer, but their clinical impact is often impaired by acquired drug resistance through the secondary T790M EGFR mutation. To overcome this problem, we analysed the metabonomic differences between two independent pairs of erlotinib-sensitive/resistant cells and discovered that glutathione (GSH) levels were significantly reduced in T790M EGFR cells. We also found that increasing GSH levels in erlotinib-resistant cells re-sensitised them, whereas reducing GSH levels in erlotinib-sensitive cells made them resistant. Decreased transcription of the GSH-synthesising enzymes (GCLC and GSS) due to the inhibition of NRF2 was responsible for low GSH levels in resistant cells that was directly linked to the T790M mutation. T790M EGFR clinical samples also showed decreased expression of these key enzymes; increasing intra-tumoural GSH levels with a small-molecule GST inhibitor re-sensitised resistant tumours to erlotinib in mice. Thus, we identified a new resistance pathway controlled by EGFR T790M and a therapeutic strategy to tackle this problem in the clinic

    MMI reflectors with free selection of reflection to transmission ratio

    Get PDF
    We investigate a new class of integrated mirrors, so called MMI reflectors. In addition to one-port full reflectors, we introduce two-port MMI reflectors, capable of both reflection and transmission. The reflection to transmission ratio in these devices can be set freely by changing their geometry. This is deinonstrated through numerical simulations as well as through a set ofworking devices realized on an indium phosphide layer stack

    Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer

    Get PDF
    Aims Lymphovascular space invasion (LVSI) in endometrial cancer (EC) is an important prognostic variable impacting on a patient's individual recurrence risk and adjuvant treatment recommendations. Recent work has shown that grading the extent of LVSI further improves its prognostic strength in patients with stage I endometrioid EC. Despite this, there is little information on the reproducibility of LVSI assessment in EC. Therefore, we designed a study to evaluate interobserver agreement in discriminating true LVSI from LVSI mimics (Phase I) and reproducibility of grading extent of LVSI (Phase II). Methods and results Scanned haematoxylin and eosin (H&E) slides of endometrioid EC (EEC) with a predefined possible LVSI focus were hosted on a website and assessed by a panel of six European gynaecological pathologists. In Phase I, 48 H&E slides were included for LVSI assessment and in Phase II, 42 H&E slides for LVSI grading. Each observer was instructed to apply the criteria for LVSI used in daily practice. The degree of agreement was measured using the two-way absolute agreement average-measures intraclass correlation coefficient (ICC). Reproducibility of LVSI assessment (ICC = 0.64, P < 0.001) and LVSI grading (ICC = 0.62, P < 0.001) in EEC was substantial among the observers. Conclusions Given the good reproducibility of LVSI, this study further supports the important role of LVSI in decision algorithms for adjuvant treatment
    • 

    corecore